News of Bahrain
World28 October 20212 min read

Oman recognises Covaxin as approved vaccine for entering country without quarantine

TDT | Manama The Daily Tribune – www.newsofbahrain.com The government of Oman on Wednesday added Bharat Biotech's Covaxin to the approved list of Covid vaccines for travel to the country. All passengers from India who have received two doses of Covaxin at-least 14 days befo

Editorial Team Legacy

Published 28 October 2021, 8:00 · Updated 21:29

Link copied
Oman recognises Covaxin as approved vaccine for entering country without quarantine

TDT | Manama

The Daily Tribune – www.newsofbahrain.com

The government of Oman on Wednesday added Bharat Biotech's Covaxin to the approved list of Covid vaccines for travel to the country. All passengers from India who have received two doses of Covaxin at-least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine.

However, all other Covid related requirements/conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers.

The approval will significantly ease travel to Oman for Indians who have taken Covaxin. Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.

The government of Oman on Wednesday added Bharat Biotech's Covaxin to the approved list of Covid vaccines for travel to the country. All passengers from India who have received two doses of Covaxin at-least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine.

However, all other Covid related requirements/conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers.

The approval will significantly ease travel to Oman for Indians who have taken Covaxin. Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine

Join the conversation

Sign in to leave a comment. Every comment is reviewed before it goes live.

No comments yet. Start the conversation.